Join our email list to stay up to date on the latest Amyloidosis news.

ARC welcomes Jan Griffin, MD, amyloidosis cardiologist at the Medical University of South Carolina. Dr. Griffin will discuss how ATTR affects the heart and explore the evolution of treatments for ATTR-CM.

She will cover what the available drugs are, how they work (and how do we know they are working), and what’s next on the horizon.

The webinar concludes with a Q and A session.

 

 

Was the information on this page helpful?
YesNo
*

*

*









*